Cognate Th2-B cell interaction is essential for the autoantibody production in pemphigus vulgaris

Journal of Clinical Immunology

Volumn 32, Issue 1, 2012, Pages 114-123

  Zhu, Haiqin ^a   Chen, Yayuan ^a   Zhou, Yun ^a   Wang, Ying ^a   Zheng, Jie ^a   Pan, Meng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Dsg3; Igg4 subclass; Pemphigus vulgaris; Th2 cell

Indexed keywords

ALUMINUM HYDROXIDE; AUTOANTIBODY; DSG3 PROTEIN; FREUND ADJUVANT; IMMUNOGLOBULIN G1; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG; AUTOANTIGEN; DESMOGLEIN; DESMOGLEIN 3; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BLOOD; CD4+ T LYMPHOCYTE; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NONHUMAN; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; SPLEEN; TH2 CELL; ADOPTIVE TRANSFER; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL COMMUNICATION; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PEMPHIGUS; TH1 CELL;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; DESMOGLEIN 3; DESMOGLEINS; HUMANS; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEMPHIGUS; TH1 CELLS; TH2 CELLS;

EID: 84862261531     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-011-9597-4     Document Type: Article

References (29)

1. Amagai M. Pemphigus: autoimmunity to epidermal cell adhesion molecules. Advances in Dermatology. 1996;11:319-52.
2. Payne AS, Hanakawa Y, Amagai M, Stanley JR. Desmosomes and disease: pemphigus and bullous impetigo. Current Opinion in Cell Biology. 2004;16:536-43. (Pubitemid 39201238)
3. Stanley JR. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous disease due to defective epidermal cell adhesion. Advances in Immunology. 1993;53:291-325.
4. Hertl M, Veldman C. Pemphigus-paradigm of autoantibodymediated autoimmunity. Skin Pharmacology and Applied Skin Physiology. 2001;14:408-18.
5. Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. The New England Journal of Medicine. 1982;306:1189-96. (Pubitemid 12158848)
6. Lin MS, Swartz SJ, Lopez A, Ding X, Fernandez-Vina MA, Stastny P, et al. Development and characterization of desmoglein3 specific T cells from patients with pemphigus vulgaris. The Journal of Clinical Investigation. 1997;99:31-40. (Pubitemid 27058291)
7. Hertl M, Amagai M, Sundaram H, Stanley J, Ishii K, Katz SI. Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals. The Journal of Investigative Dermatology. 1998;110:62-6. (Pubitemid 28086065)
8. Nishifuji K, Amagai M, Kuwana M, Toshiro I, Takeji N. Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production. The Journal of Investigative Dermatology. 2000;114:88-94. (Pubitemid 30195978)
9. Takahashi H, Kuwana M, Amagai M. A single helper T cell clone is sufficient to commit polyclonal naive B cells to produce pathogenic IgG in experimental pemphigus vulgaris. Journal of Immunology. 2009;182:1740-5.
10. Veldman CM, Gebhard KL, Uter W, Wassmuth R, Grotzinger J, Schultz E, et al. T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals. Journal of Immunology. 2004;172:3883-92. (Pubitemid 38337976)
11. Rizzo C, Fotino M, Zhang Y, Chow S, Spizuoco A, Sinha AA. Direct characterization of human T cells in pemphigus vulgaris reveals elevated autoantigen-specific Th2 activity in association with active disease. Clinical and Experimental Dermatology. 2005;30:535-40. (Pubitemid 41076023)
12. Torzecka JD, Wozniak K, Kowalewski C, Waszczykowska E, Sysa-Jedrzejowska A, Pas HH, et al. Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: coincidental phenomenon with a risk of disease development? Archives of Dermatological Research. 2007;299:239-43. (Pubitemid 47222922)
13. Sitaru C, Mihai S, Zillikens D. The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases. Archives of Dermatological Research. 2007;299:1-8. (Pubitemid 46723573)
14. Bhol K, Mohimen A, Ahmed R. Correlation of subclasses of IgG with disease activity in pemphigus vulgaris. Dermatologica. 1994;189:85-9. (Pubitemid 24141436)
15. Green MG, Bystryn JC. Effect of intravenous immunoglobulin therapy on serum levels of IgG1 and IgG4 antidesmoglein 1 and antidesmoglein 3 antibodies in pemphigus vulgaris. Archives of Dermatology. 2008;144:1621-4.
16. Harman KE, Albert S, Black MM. Guidelines for the management of pemphigus vulgaris. The British Journal of Dermatology. 2003;149:926-37. (Pubitemid 37541976)
17. Kwon EJ, Yamagami J, Nishikawa T, Amagai M. Antidesmoglein IgG autoantibodies in patients with pemphigus in remission. Journal of the European Academy of Dermatology and Venereology. 2008;22:1070-5.
18. Ishii K, Amagai M, Hall RP, Hashimoto T, Takayanagi A, Gamou S, et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. Journal of Immunology. 1997;159:2010-7. (Pubitemid 127484192)
19. Petersen CM, Christensen EI, Andresen BS, Moller BK. Internalization, lysosomal degradation and new synthesis of surface membrane CD4 in phorbol ester-activated T-lymphocytes and U-937 cells. Experimental Cell Research. 1992;201:160-73.
20. Markovic-Plese S, Pinilla C, Martin R. The initiation of the autoimmune response in multiple sclerosis. Clinical Neurology and Neurosurgery. 2004;106:218-22. (Pubitemid 38716149)
21. Kuwana M, Ikeda Y. The role of autoreactive T-cells in the pathogenesis of idiopathic thrombocytopenic purpura. International Journal of Hematology. 2005;81:106-12. (Pubitemid 40270981)
22. Veldman C, Eming R, Wolff-Franke S, Sonderstrup G, Kwok WW, Hertl M. Detection of low avidity desmoglein 3-reactive T cells in pemphigus vulgaris using HLA-DR beta 1*0402 tetramers. Clinical Immunology. 2007;122:330-7. (Pubitemid 46223650)
23. Veldman C, Stauber A, Wassmuth R, Uter W, Schuler G, Hertl M. Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles. Journal of Immunology. 2003;170:635-42. (Pubitemid 36026193)
24. Finkelman FD, Holmes J, Katona IM, Urban JF, Beckmann MP, Park LS, et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annual Review of Immunology. 1990;8:303-33.
25. Kotowicz K, Callard RE. Human immunoglobulin class and IgG subclass regulation: dual action of interleukin-4. European Journal of Immunology. 1993;23:2250-6. (Pubitemid 23265890)
26. Pan M, Zhou Y. WP Li, J. Zheng. Modulation of desmoglein-3specific T cell response and pathogenic antibody generation in mice. Immunology Letters. 2008;120:6-13.
27. Aalberse RC, Stapel SO, Schuurman J, Rispens T. Immunoglobulin G4: an odd antibody. Clinical and Experimental Allergy. 2009;39:469-77.
28. Anzai H, Fujii Y, Nishifuji K, Aoki-Ota M, Ota T, Amagai M, et al. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris. Journal of Dermatological Science. 2004;35:133-42. (Pubitemid 38969036)
29. Sekiguchi M, Futei Y, Fujii Y, Iwasaki T, Nishikawa T, Amagai M. Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. Journal of Immunology. 2001;167:5439-48. (Pubitemid 33009785)